Chinese medicinal decoction for treating bronchiectasis

Abstract

The invention discloses a Chinese medicinal decoction for treating bronchiectasis. The Chinese medicinal decoction comprises the following raw materials by weight part: 6-7 of astragalus, 2-4 of stir-fried scutellaria baicalensis, 5-10 of thunberg fritillary bulb, 10-12 of Chinese yam, 3-4 of rehmannia glutinosa, 2-4 of dried tangerine peel, 15-20 of honey-fried licorice root, 5-6 of Poria cocos, 2-4 of Cortex Lycii, 5-6 of platycladus orientalis leaf, 10-15 of loquat leaf, 4-5 of radish seed, 2-4 of Houttuynia cordata, 4-5 of cuttlebone, 5-7 of Roripa montana, 6-8 of jasmine flower, 2-4 of Syzygium jambos pericarp, and 1-3 of Root of Himalayan Prinsepia. The Chinese medicinal decoction provided by the invention has the efficacy of exterior syndrome relieving and pathogenic factor dispelling, lung qi ventilating and phlegm dissipating, qi depressing, cough and asthma relieving, qi benefiting and basis consolidating, wind dispelling and qi regulating, pungent-cool dispersion, heat clearing and yin nourishing, can achieve the effects of relieving cough, reducing phlegm and diminishing inflammation together, effectively eliminates cough, excessive phlegm and other symptoms caused by bronchiectasis, and has a cure rate up to 98%.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction for treating bronchiectasis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Bronchiectasis refers to the abnormal, irreversible expansion and deformation of the lumen of the proximal medium-sized bronchus due to the destruction of the muscle and elastic components of the tube wall; most of the disease is acquired, and it is more common in children and young people; the clinical manifestations are mainly Chronic cough, coughing up a large amount of purulent sputum, or repeated hemoptysis; current clinical treatment is mainly anti-inflammatory, phlegm-resolving, and asthma-relieving, or surgical resection, but the therapeutic effect is not satisfactory. Some patients have long-term dependence on drugs and have developed drug resistance, with many side effects , so that the patient's immune function is reduced, and the viscera is dysfunction...

AI Technical Summary

Problems solved by technology

[0002] Bronchiectasis refers to the abnormal, irreversible dilation and deformation of the lumen of the proximal medium-sized bronchus due to the destruction of the muscle and elastic components of the tube wall; most of the disease is acquired, and it is more common in children and young people; the clinical manifestations are mainly Chronic cough, coughing up a large amount of purulent sputum, or repeated hemoptysis; current clinical treatment is mainly anti-inflammatory, phlegm-resolving, asthma-relieving, or surgical resection. , so that the patient's immune function is reduced, and the viscera is dysfunctional